Related Experiment Video
Updated: May 21, 2026
08:23
LAD-Ligation: A Murine Model of Myocardial Infarction
Published on: October 14, 2009
SDF-1 in myocardial repair
M S Penn1, J Pastore, T Miller
1Summa Cardiovascular Institute, Summa Health System, Akron, OH, USA. mpenn2@neomed.edu
Gene Therapy
|June 8, 2012
Summary
Stem cell therapy shows promise for ischemic heart disease. The stromal cell-derived factor-1 (SDF-1):CXCR4 pathway is critical for cardiac repair, influencing stem cell homing and survival.
Area of Science:
- Cardiovascular Research
- Regenerative Medicine
- Stem Cell Biology
Background:
- Stem cell therapy offers potential for treating cardiac dysfunction in ischemic heart disease.
- Early clinical trials indicate safety and feasibility.
- Laboratory studies explore mechanisms and optimization of cardiac regenerative therapies.
Purpose of the Study:
- To highlight the critical role of the stromal cell-derived factor-1 (SDF-1):CXCR4 pathway in stem cell-mediated cardiac repair.
- To emphasize the importance of understanding this pathway for designing effective clinical studies.
Main Methods:
- Review of preclinical (animal models of myocardial infarction and heart failure) and early clinical studies.
- Analysis of the SDF-1:CXCR4 axis's impact on stem cell homing, myocyte survival, and ventricular remodeling.
Main Results:
- The SDF-1:CXCR4 pathway is crucial for stem cell-based cardiac repair.
- Evidence suggests SDF-1 alone can induce cardiac repair.
- This pathway influences key aspects of cardiac regeneration.
Conclusions:
- Understanding the SDF-1:CXCR4 axis is essential for advancing stem cell therapy in cardiology.
- Ignoring these mechanisms may lead to poorly designed studies and negative outcomes.
- Further research and clinical application should focus on leveraging the SDF-1:CXCR4 pathway for cardiac regeneration.
